Home/Filings/4/0001209191-23-015577
4//SEC Filing

Terrillion Scott 4

Accession 0001209191-23-015577

CIK 0001346830other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:38 PM ET

Size

5.6 KB

Accession

0001209191-23-015577

Insider Transaction Report

Form 4
Period: 2023-03-01
Terrillion Scott
SEC'Y; CHIEF COMPLIANCE & G.C.
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-01+81,00081,000 total
    Exercise: $10.06Exp: 2033-03-01Common Stock (81,000 underlying)
Footnotes (1)
  • [F1]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 1, 2023, in each case subject to the Reporting Person's continued service as of each such date.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0001706426

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:38 PM ET
Size
5.6 KB